The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Cindy Neunert, Wendy Lim, Mark Crowther, Alan Cohen, Lawrence Solberg, Mark A. Crowther

Research output: Contribution to journalReview article

1014 Citations (Scopus)

Abstract

Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the American Society of Hematology published a landmark guidance paper designed to assist clinicians in the management of this disorder. Since 1996 there have been numerous advances in the management of both adult and pediatric ITP. These changes mandated an update in the guidelines. This guideline uses a rigorous, evidence-based approach to the location, interpretation, and presentation of the available evidence. We have endeavored to identify, abstract, and present all available methodologically rigorous data informing the treatment of ITP. We provide evidence-based treatment recommendations using the GRADE system in those areas in which such evidence exists. We do not provide evidence in those areas in which evidence is lacking, or is of lower quality - interested readers are referred to a number of recent, consensus-based recommendations for expert opinion in these clinical areas. Our review identified the need for additional studies in many key areas of the therapy of ITP such as comparative studies of "front-line" therapy for ITP, the management of serious bleeding in patients with ITP, and studies that will provide guidance about which therapy should be used as salvage therapy for patients after failure of a first-line intervention.

Original languageEnglish (US)
Pages (from-to)4190-4207
Number of pages18
JournalBlood
Volume117
Issue number16
DOIs
StatePublished - Apr 21 2011

Fingerprint

Idiopathic Thrombocytopenic Purpura
Evidence-Based Practice
Practice Guidelines
Salvaging
Pediatrics
Guidelines
Therapeutics
Salvage Therapy
Expert Testimony
Hemorrhage

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., & Crowther, M. A. (2011). The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood, 117(16), 4190-4207. https://doi.org/10.1182/blood-2010-08-302984

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. / Neunert, Cindy; Lim, Wendy; Crowther, Mark; Cohen, Alan; Solberg, Lawrence; Crowther, Mark A.

In: Blood, Vol. 117, No. 16, 21.04.2011, p. 4190-4207.

Research output: Contribution to journalReview article

Neunert, C, Lim, W, Crowther, M, Cohen, A, Solberg, L & Crowther, MA 2011, 'The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia', Blood, vol. 117, no. 16, pp. 4190-4207. https://doi.org/10.1182/blood-2010-08-302984
Neunert, Cindy ; Lim, Wendy ; Crowther, Mark ; Cohen, Alan ; Solberg, Lawrence ; Crowther, Mark A. / The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. In: Blood. 2011 ; Vol. 117, No. 16. pp. 4190-4207.
@article{7736d1ea0493428895e5569d57427e3f,
title = "The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia",
abstract = "Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the American Society of Hematology published a landmark guidance paper designed to assist clinicians in the management of this disorder. Since 1996 there have been numerous advances in the management of both adult and pediatric ITP. These changes mandated an update in the guidelines. This guideline uses a rigorous, evidence-based approach to the location, interpretation, and presentation of the available evidence. We have endeavored to identify, abstract, and present all available methodologically rigorous data informing the treatment of ITP. We provide evidence-based treatment recommendations using the GRADE system in those areas in which such evidence exists. We do not provide evidence in those areas in which evidence is lacking, or is of lower quality - interested readers are referred to a number of recent, consensus-based recommendations for expert opinion in these clinical areas. Our review identified the need for additional studies in many key areas of the therapy of ITP such as comparative studies of {"}front-line{"} therapy for ITP, the management of serious bleeding in patients with ITP, and studies that will provide guidance about which therapy should be used as salvage therapy for patients after failure of a first-line intervention.",
author = "Cindy Neunert and Wendy Lim and Mark Crowther and Alan Cohen and Lawrence Solberg and Crowther, {Mark A.}",
year = "2011",
month = "4",
day = "21",
doi = "10.1182/blood-2010-08-302984",
language = "English (US)",
volume = "117",
pages = "4190--4207",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "16",

}

TY - JOUR

T1 - The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

AU - Neunert, Cindy

AU - Lim, Wendy

AU - Crowther, Mark

AU - Cohen, Alan

AU - Solberg, Lawrence

AU - Crowther, Mark A.

PY - 2011/4/21

Y1 - 2011/4/21

N2 - Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the American Society of Hematology published a landmark guidance paper designed to assist clinicians in the management of this disorder. Since 1996 there have been numerous advances in the management of both adult and pediatric ITP. These changes mandated an update in the guidelines. This guideline uses a rigorous, evidence-based approach to the location, interpretation, and presentation of the available evidence. We have endeavored to identify, abstract, and present all available methodologically rigorous data informing the treatment of ITP. We provide evidence-based treatment recommendations using the GRADE system in those areas in which such evidence exists. We do not provide evidence in those areas in which evidence is lacking, or is of lower quality - interested readers are referred to a number of recent, consensus-based recommendations for expert opinion in these clinical areas. Our review identified the need for additional studies in many key areas of the therapy of ITP such as comparative studies of "front-line" therapy for ITP, the management of serious bleeding in patients with ITP, and studies that will provide guidance about which therapy should be used as salvage therapy for patients after failure of a first-line intervention.

AB - Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the American Society of Hematology published a landmark guidance paper designed to assist clinicians in the management of this disorder. Since 1996 there have been numerous advances in the management of both adult and pediatric ITP. These changes mandated an update in the guidelines. This guideline uses a rigorous, evidence-based approach to the location, interpretation, and presentation of the available evidence. We have endeavored to identify, abstract, and present all available methodologically rigorous data informing the treatment of ITP. We provide evidence-based treatment recommendations using the GRADE system in those areas in which such evidence exists. We do not provide evidence in those areas in which evidence is lacking, or is of lower quality - interested readers are referred to a number of recent, consensus-based recommendations for expert opinion in these clinical areas. Our review identified the need for additional studies in many key areas of the therapy of ITP such as comparative studies of "front-line" therapy for ITP, the management of serious bleeding in patients with ITP, and studies that will provide guidance about which therapy should be used as salvage therapy for patients after failure of a first-line intervention.

UR - http://www.scopus.com/inward/record.url?scp=79955984501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955984501&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-08-302984

DO - 10.1182/blood-2010-08-302984

M3 - Review article

C2 - 21325604

AN - SCOPUS:79955984501

VL - 117

SP - 4190

EP - 4207

JO - Blood

JF - Blood

SN - 0006-4971

IS - 16

ER -